BAC
Bank of America Corporation
BAC has a slight edge over CRVL overall, supported by stronger modeled upside and lower modeled downside.
CRVL
CorVel Corporation
CRVL offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
CRVL Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| N/A | |
| N/A |
CRVL's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like CRVL.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over CRVL in the historical PE scenario, which offers more potential upside but is not a forecast.
CRVL PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 32x | $76.95 | -11% |
| Current | 36x | $86.50 | — |
| Fair | 47x | $111 | +29% |
| Expensive | 59x | $141 | +63% |
Historical ranges are pointers, not guarantees.
CRVL's PE is in its cheap range at 36x.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
CRVL Forward outlook
There aren't enough analyst estimates for CRVL to show an outlook.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over CRVL on earnings, with stronger typical year-over-year growth.
CRVL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $2.38 | +18% |
| Q2 2026 | $2.25 | +17% |
| Q1 2026 | $2.14 | +17% |
| Q4 2025 | $2.03 | +19% |
| Q3 2025 | $2.02 | +29% |
| Q2 2025 | $1.93 | +29% |
| Q1 2025 | $1.83 | +24% |
| Q4 2024 | $1.70 | +18% |
CRVL's earnings per share have climbed steadily: $2.38 over the past year, up 18% from the year before, and higher year over year for 22 quarters in a row.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over CRVL on profitability, with a higher operating margin.
CRVL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $267.1M | +11% |
| Q2 2026 | $259.9M | +11% |
| Q1 2026 | $248.5M | +7.4% |
| Q4 2025 | $235.6M | +3.4% |
| Q3 2025 | $239.6M | +6.8% |
| Q2 2025 | $234.7M | +11% |
| Q1 2025 | $231.5M | +12% |
| Q4 2024 | $228M | +13% |
CRVL has the edge over BAC on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 17% | +2.2 points |
| Q2 2026 | 17% | +1.6 points |
| Q1 2026 | 16% | +1.6 points |
| Q4 2025 | 14% | +0.2 points |
| Q3 2025 | 15% | +2.2 points |
| Q2 2025 | 15% | +1.8 points |
| Q1 2025 | 14% | +3.5 points |
| Q4 2024 | 14% | +2.5 points |
CRVL's operating margin was 17% last quarter, up 2.2 points from the same quarter a year ago, near the top of its range since 2019.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
CRVL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $29.3M | +92% |
| Q2 2026 | $43.1M | +8.9% |
| Q1 2026 | $20.3M | +42% |
| Q4 2025 | $35.2M | +9.5% |
| Q3 2025 | $15.3M | +23% |
| Q2 2025 | $39.5M | +21% |
| Q1 2025 | $14.3M | +174% |
| Q4 2024 | $32.1M | +43% |
CRVL has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over CRVL on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
CRVL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.5% | -238K shares |
| 1 year | -2% | -1M shares |
| 3 years | -2.6% | -1.3M shares |
| 5 years | -7.3% | -4M shares |
| Available history | -8.8% | -4.9M shares |
CRVL has 51M diluted shares, down 2% from a year ago, with $74M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $18.6M |
| Q2 2026 | $22M |
| Q1 2026 | $20.2M |
| Q4 2025 | $13.6M |
| Q3 2025 | $12.8M |
| Q2 2025 | $9.6M |
| Q1 2025 | $9M |
| Q4 2024 | $9.5M |
CRVL spent $74M buying back its own shares over the past year, up 82% from the year before.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
CRVL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.4x | Net Cash |
| Q2 2026 | -1.4x | Net Cash |
| Q1 2026 | -1.3x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -1.3x | Net Cash |
| Q2 2025 | -1.3x | Net Cash |
| Q1 2025 | -1.1x | Net Cash |
| Q4 2024 | -1.2x | Net Cash |
CRVL has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
CRVL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 76.6 | Overbought |
| Stochastic | 85.6 | Overbought |
CRVL's weekly RSI is 77 (overbought) and its Stochastic is 86 (overbought).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over CRVL on valuation relative to its sector.
CRVL PE vs Financial Services Sector
| Metric | CRVL | Sector median | Relative |
|---|---|---|---|
| PE | 36x | 13x | 179% above |
| PE % | 24 | 63 | 39 pts below |
CRVL is trading at 36x earnings, a 179% premium to the Financial Services sector's median of 13x.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
CRVL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $80.3 | 7.7% above |
| 20 week MA | $71.3 | 21% above |
| 50 week MA | $64.4 | 34% above |
| 100 week MA | $81.5 | 6.2% above |
| 200 week MA | $80.9 | 7% above |
CRVL has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
CRVL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $28.8 | $34.7 | +21% |
| 2021 | $34.7 | $66.1 | +90% |
| 2022 | $66.1 | $48.0 | -27% |
| 2023 | $48.0 | $82.4 | +72% |
| 2024 | $82.4 | $113.7 | +38% |
| 2025 | $113.7 | $69.1 | -39% |
| 2026 YTD | $69.1 | $86.5 | +25% |
CRVL has the edge over BAC on returns for 2026, with the stronger performance.